ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,459,941, issued on Nov. 4, was assigned to Rigel Pharmaceuticals Inc. (South San Francisco, Calif.).
"Tricyclic IRAK inhibitors" was invented by Zhushou Luo (South San Francisco, Calif.), Simon Shaw (South San Francisco, Calif.), Ihab Darwish (South San Francisco, Calif.), Esteban Masuda (South San Francisco, Calif.) and Chrystelle Lamagna (South San Francisco, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed embodiments concern compounds according to Formula IIn some embodiments, the compounds are useful as kinase inhibitors, such as interleukin receptor associated kinases (IRAK) inhibitors. Also disclosed are compositions comprising such...